© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
January 14, 2021
The SOLOIST-WHF trial indicates that SGLT2 inhibition may lead to an overall reduction in cardiovascular-related deaths and hospitalizations.
January 13, 2021
A conversation on how associations between the chronic conditions have become better understood in 10 years.
January 08, 2021
If approved, the treatment would be the first SGLT2 inhibitor for patients with chronic kidney disease.
January 07, 2021
A lipidologist from Connecticut describes his experience during the COVID-19 pandemic and explains why he sees getting the vaccine as his "biggest contribution" to healthcare during the pandemic.
January 06, 2021
Further investigation needs to be done to determine whether this increase is due to the effects of lockdowns or the virus itself.
January 05, 2021
The burden of cardiovascular disease is particularly high in African Americans, a population that typically faces health disparities.
Patients who continue RAS therapy had a lower risk of kidney replacement therapy.
December 30, 2020
Elevated cardiac troponins during hospitalization for influenza is associated with heightened risk of mortality after hospital discharge.
December 23, 2020
Investigators from the University of California used a 3D silicone model of blood vessels in the brain to help elucidate this uncertain relationship.